Replies to post #76830 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

Yeah, but Biogen has the money to do that. Gawd, how much does BP spent on their Alzheimers trials that go on for years and years and then they parse data looking for an effective subset?

Biogen has money and needs drugs. Anavex has a dynamite drug and needs money :)

[stockaesthetics]

OK so my reference on timeline of Ph 2 was wrong, but I disagree that they, at least initially, will be doing "shots in the dark" regarding 2-73. That's not how science works, not in academia and especially not in pharma. They must have some data that suggests or reason to believe that 2-73 may have an effect on differentiation of OPCs, otherwise they wouldn't be doing the experiment. They may do further exploratory studies to test other avenues with 2-73, but that by no way means they are "shooting in the dark."